What does APOTHEEK PIERLET do?

APOTHEEK PIERLET is a pharmacy in Riemst. Private Limited, started on 2 October 2017, 1 establishment.

What is the address of APOTHEEK PIERLET?

The registered office of APOTHEEK PIERLET is located at Elderenweg 26, 3770 Riemst.

Is APOTHEEK PIERLET still active?

Yes. According to the CBE (30 October 2026) APOTHEEK PIERLET is active, legal situation “Normale toestand”, started on 2 October 2017.

Is APOTHEEK PIERLET registered on Peppol?

Yes, APOTHEEK PIERLET is registered on the Peppol network with ID 0208:0681994825.

What is the enterprise number of APOTHEEK PIERLET?

The enterprise number of APOTHEEK PIERLET is BE0681994825.

When was APOTHEEK PIERLET founded?

APOTHEEK PIERLET was founded on 2 October 2017.

Who are the directors of APOTHEEK PIERLET?

According to the 2025 annual accounts, the directors of APOTHEEK PIERLET are: Helena Pierlet.

Is APOTHEEK PIERLET a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 October 2017; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK PIERLET make in 2025?

APOTHEEK PIERLET posted a profit after taxes of € 78,040 in financial year 2025.

What is the revenue of APOTHEEK PIERLET?

As a small company, APOTHEEK PIERLET is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 100,223.

APOTHEEK PIERLET (Private Limited) - Riemst

Dossier APOTHEEK PIERLET, printed on 30 October 2026 from databakkes.be/en/0681994825/apotheek-pierlet. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 13 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

APOTHEEK PIERLET from Riemst, company number BE0681994825, closed financial year 2025 with a result of € 78,040 after tax. For that financial year APOTHEEK PIERLET recorded a gross margin of € 100,223 and equity of € 77,994. Compared with financial year 2024, the result moved from € 74,361 to € 78,040. Profitable, and profit is growing. The buffer shrank hard: equity is 74 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 5, 2026.

What it is worth Shrank hard

€ 77,994

▼ 74% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 78,040

▲ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 24,143

▲ € 23,388 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 305,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Wage cost

€ 2,539

▲ € 2,507 vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 21,073

▼ 30% vs 2024

Of which on lease € 21,073.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 545,808

▲ 10% vs 2024

€ 74,997 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 1,621

▲ 40% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 40,454

▲ € 36,067 vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 114,245 Gross margin 2022: € 114,245 First fiscal year in the series	€ 82,198 Gross margin 2023: € 82,198 ▼ 28% vs 2022 (€ 114,245) Unfavourable step	€ 121,157 Gross margin 2024: € 121,157 ▲ 47% vs 2023 (€ 82,198) Favourable step	€ 100,223 Gross margin 2025: € 100,223 ▼ 17% vs 2024 (€ 121,157) Unfavourable step	▼ 17%
Profit after taxes	€ 78,919 Profit after taxes 2022: € 78,919 First fiscal year in the series	€ 46,667 Profit after taxes 2023: € 46,667 ▼ 41% vs 2022 (€ 78,919) Unfavourable step	€ 74,361 Profit after taxes 2024: € 74,361 ▲ 59% vs 2023 (€ 46,667) Favourable step	€ 78,040 Profit after taxes 2025: € 78,040 ▲ 5% vs 2024 (€ 74,361) Favourable step	▲ 5%
Equity	€ 183,925 Equity 2022: € 183,925 First fiscal year in the series	€ 230,592 Equity 2023: € 230,592 ▲ 25% vs 2022 (€ 183,925) Favourable step	€ 304,953 Equity 2024: € 304,953 ▲ 32% vs 2023 (€ 230,592) Favourable step	€ 77,994 Equity 2025: € 77,994 ▼ 74% vs 2024 (€ 304,953) Unfavourable step	▼ 74%
Total debts	€ 620,955 Total debts 2022: € 620,955 First fiscal year in the series	€ 598,842 Total debts 2023: € 598,842 ▼ 4% vs 2022 (€ 620,955) Favourable step	€ 546,138 Total debts 2024: € 546,138 ▼ 9% vs 2023 (€ 598,842) Favourable step	€ 813,402 Total debts 2025: € 813,402 ▲ 49% vs 2024 (€ 546,138) Unfavourable step	▲ 49%
Cash	€ 3,842 Cash 2022: € 3,842 First fiscal year in the series	€ 4,840 Cash 2023: € 4,840 ▲ 26% vs 2022 (€ 3,842) Favourable step	€ 755 Cash 2024: € 755 ▼ 84% vs 2023 (€ 4,840) Unfavourable step	€ 24,143 Cash 2025: € 24,143 ▲ € 23,388 vs 2024 (€ 755) Favourable step	▲ € 23,388
Land & buildings	€ 144,049 Land & buildings 2022: € 144,049 First fiscal year in the series	€ 139,796 Land & buildings 2023: € 139,796 ▼ 3% vs 2022 (€ 144,049) Unchanged	€ 134,666 Land & buildings 2024: € 134,666 ▼ 4% vs 2023 (€ 139,796) Unchanged	€ 189,536 Land & buildings 2025: € 189,536 ▲ 41% vs 2024 (€ 134,666) Unchanged	▲ 41%
Retained profit	€ 165,325 Retained profit 2022: € 165,325 First fiscal year in the series	€ 211,992 Retained profit 2023: € 211,992 ▲ 28% vs 2022 (€ 165,325) Favourable step	€ 286,353 Retained profit 2024: € 286,353 ▲ 35% vs 2023 (€ 211,992) Favourable step	€ 59,394 Retained profit 2025: € 59,394 ▼ 79% vs 2024 (€ 286,353) Unfavourable step	▼ 79%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 305,000 Dividend 2025: € 305,000 Unchanged (€ 0) Unchanged
Bank debt	€ 560,552 Bank debt 2022: € 560,552 First fiscal year in the series	€ 548,740 Bank debt 2023: € 548,740 ▼ 2% vs 2022 (€ 560,552) Favourable step	€ 497,687 Bank debt 2024: € 497,687 ▼ 9% vs 2023 (€ 548,740) Favourable step	€ 545,808 Bank debt 2025: € 545,808 ▲ 10% vs 2024 (€ 497,687) Unfavourable step	▲ 10%
Balance sheet total	€ 804,880 Balance sheet total 2022: € 804,880 First fiscal year in the series	€ 829,434 Balance sheet total 2023: € 829,434 ▲ 3% vs 2022 (€ 804,880) Unchanged	€ 851,091 Balance sheet total 2024: € 851,091 ▲ 3% vs 2023 (€ 829,434) Unchanged	€ 891,395 Balance sheet total 2025: € 891,395 ▲ 5% vs 2024 (€ 851,091) Unchanged	▲ 5%

Key figures of APOTHEEK PIERLET, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK PIERLET?

What happened at APOTHEEK PIERLET in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 5, 2026 New annual accounts for financial year 2025: profit of € 78,040 (▲ 5% vs 2024). filed late Source: NBB ↗
Oct 2, 2017 New establishment in Riemst. KBO
Oct 2, 2017 Start of the company according to the CBE. KBO

In short

From € 78,919 profit in 2022 to € 78,040 profit in 2025.

Paid € 62,501 in corporate taxes since 2022.

Best year ever: 2022, with € 78,919 profit.

Paid out € 305,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Helena Pierlet

APOTHEEK PIERLET

Milpharma 100%

Behind APOTHEEK PIERLET is Helena Pierlet. It owns 100% of Milpharma itself.

Directors

According to the 2025 annual accounts

Helena Pierlet

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Elderenweg 26

3770 Riemst

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

MILPHARMA same network

€ 133,781 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0681.994.825

VAT number

BE 0681.994.825

Registered office

Elderenweg 26, 3770 Riemst

Names & denominations

APOTHEEK PIERLET

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

2 October 2017

Peppol

Active · Active since 26 Jun 2025

Activities · NACE

Detailhandel in farmaceutische producten

Vervaardiging van overige farmaceutische producten

Vervaardiging van geneesmiddelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK PIERLET

Warning lights

Financials

What happened to APOTHEEK PIERLET?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions